Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Min Qui

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Oncology Reports|November 16, 2012
Ophiopogonin B-induced autophagy in non-small cell lung cancer cells via inhibition of the PI3K/Akt signaling pathwayMeijuan Chen, Yuhong Du, Min Qui, et al.
British Journal of Cancer|July 20, 2023
Nicardipine is a putative EED inhibitor and has high selectivity and potency against chemoresistant prostate cancer in preclinical modelsXin Li, Yanhua Chen, Lijuan Bai, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Constitutively synergistic multiagent drug formulations targeting MERTK, FLT3, and BCL-2 for treatment of AMLJames M Kelvin, Juhi Jain, Aashis Thapa, et al.
Pharmaceutical Research|September 13, 2023
Constitutively Synergistic Multiagent Drug Formulations Targeting MERTK, FLT3, and BCL-2 for Treatment of AMLJames M Kelvin, Juhi Jain, Aashis Thapa, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 4, 2010
Implementation of a fluorescence-based screening assay identifies histamine H3 receptor antagonists clobenpropit and iodophenpropit as subunit-selective N-methyl-D-aspartate receptor antagonistsKasper B Hansen, Praseeda Mullasseril, Sara Dawit, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 5, 2023
Development of constitutively synergistic nanoformulations to enhance chemosensitivity in T-cell leukemiaJames M Kelvin, Madison L Chimenti, Dan Y Zhang, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Oncology Reports|November 16, 2012
Ophiopogonin B-induced autophagy in non-small cell lung cancer cells via inhibition of the PI3K/Akt signaling pathwayMeijuan Chen, Yuhong Du, Min Qui, et al.
British Journal of Cancer|July 20, 2023
Nicardipine is a putative EED inhibitor and has high selectivity and potency against chemoresistant prostate cancer in preclinical modelsXin Li, Yanhua Chen, Lijuan Bai, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Constitutively synergistic multiagent drug formulations targeting MERTK, FLT3, and BCL-2 for treatment of AMLJames M Kelvin, Juhi Jain, Aashis Thapa, et al.
Pharmaceutical Research|September 13, 2023
Constitutively Synergistic Multiagent Drug Formulations Targeting MERTK, FLT3, and BCL-2 for Treatment of AMLJames M Kelvin, Juhi Jain, Aashis Thapa, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 4, 2010
Implementation of a fluorescence-based screening assay identifies histamine H3 receptor antagonists clobenpropit and iodophenpropit as subunit-selective N-methyl-D-aspartate receptor antagonistsKasper B Hansen, Praseeda Mullasseril, Sara Dawit, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 5, 2023
Development of constitutively synergistic nanoformulations to enhance chemosensitivity in T-cell leukemiaJames M Kelvin, Madison L Chimenti, Dan Y Zhang, et al.
Pageof 4